Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-26.59%
operating margin TTM
-24.8%
revenue TTM
294.21 Million
revenue per share TTM
5.72$
valuation ratios | |
|---|---|
| pe ratio | -66.87 |
| peg ratio | -1.49 |
| price to book ratio | 233.96 |
| price to sales ratio | 18.12 |
| enterprise value multiple | -74.81 |
| price fair value | 233.96 |
profitability ratios | |
|---|---|
| gross profit margin | 92.6% |
| operating profit margin | -24.8% |
| pretax profit margin | -26.66% |
| net profit margin | -26.59% |
| return on assets | -26.39% |
| return on equity | -260.01% |
| return on capital employed | -64.0% |
liquidity ratios | |
|---|---|
| current ratio | 1.39 |
| quick ratio | 1.32 |
| cash ratio | 0.69 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 219.46 |
| operating cycle | 348.85 |
| days of payables outstanding | 743.05 |
| cash conversion cycle | -394.20 |
| receivables turnover | 2.82 |
| payables turnover | 0.49 |
| inventory turnover | 1.66 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.31 |
| debt equity ratio | 4.03 |
| long term debt to capitalization | 0.73 |
| total debt to capitalization | 0.80 |
| interest coverage | -33.07 |
| cash flow to debt ratio | -0.32 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.39 |
| cash per share | 5.96 |
| operating cash flow per share | -1.38 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.32 |
| short term coverage ratios | -1.01 |
| capital expenditure coverage ratio | -268.94 |
Frequently Asked Questions
When was the last time Axsome Therapeutics, Inc. (NASDAQ:AXSM) reported earnings?
Axsome Therapeutics, Inc. (AXSM) published its most recent earnings results on 04-05-2026.
What is Axsome Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Axsome Therapeutics, Inc. (NASDAQ:AXSM)'s trailing twelve months ROE is -260.01%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Axsome Therapeutics, Inc. (AXSM) currently has a ROA of -26.39%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AXSM's net profit margin stand at?
AXSM reported a profit margin of -26.59% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AXSM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.39 in the most recent quarter. The quick ratio stood at 1.32, with a Debt/Eq ratio of 4.03.